Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Shoujie Zhao"'
Autor:
Da Chen, Zhaoming Xia, Zhixiong Guo, Wangyan Gou, Junlong Zhao, Xuemei Zhou, Xiaohe Tan, Wenbin Li, Shoujie Zhao, Zhimin Tian, Yongquan Qu
Publikováno v:
Nature Communications, Vol 14, Iss 1, Pp 1-13 (2023)
Abstract Inspired by structures of natural metalloenzymes, a biomimetic synthetic strategy is developed for scalable synthesis of porous Fe-N3 single atom nanozymes (pFeSAN) using hemoglobin as Fe-source and template. pFeSAN delivers 3.3- and 8791-fo
Externí odkaz:
https://doaj.org/article/99e4bf921b1a47babc6b3a0345ecd33c
Autor:
Tingting Bai, Enxin Wang, Shoujie Zhao, Dandan Han, Yan Zhao, Hui Chen, Jun Zhu, Tenghui Han, Yang Bai, Yanju Lou, Yongchao Zhang, Man Yang, Luo Zuo, Jiahao Fan, Xing Chen, Jia Jia, Wenbin Wu, Weirong Ren, Yejing Zhu, Shouzheng Ma, Fenghua Xu, Yuxin Tang, Xilin Du, Junlong Zhao, Jing Li, Xingshun Qi, Ying Han, Dongfeng Chen, Lei Liu
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
BackgroundAdvanced hepatocellular carcinoma (HCC) is characterized as symptomatic tumors [performance status (PS) score of 1-2], vascular invasion and extrahepatic spread, but patients with PS1 alone may be eliminated from this stage. Although liver
Externí odkaz:
https://doaj.org/article/caf2c1bb35e448a8ac9f8f59934f7c1c
Autor:
Junlong Zhao, Zhimin Tian, Shoujie Zhao, Dayun Feng, Zhixiong Guo, Liangzhi Wen, Yejing Zhu, Fenghua Xu, Jun Zhu, Shouzheng Ma, Jie Hu, Tao Jiang, Yongquan Qu, Dongfeng Chen, Lei Liu
Publikováno v:
Advanced Science, Vol 10, Iss 4, Pp n/a-n/a (2023)
Abstract Lactate, a characteristic metabolite of the tumor microenvironment (TME), drives immunosuppression and promotes tumor progression. Material‐engineered strategies for intratumoral lactate modulations demonstrate their promise for tumor immu
Externí odkaz:
https://doaj.org/article/e5266d53aa534375a2db70554e9ccfe9
Autor:
Yejing Zhu, Enxin Wang, Shoujie Zhao, Dandan Han, Yan Zhao, Hui Chen, Jun Zhu, Tenghui Han, Yang Bai, Yanju Lou, Yongchao Zhang, Man Yang, Luo Zuo, Jiahao Fan, Xing Chen, Jia Jia, Wenbin Wu, Weirong Ren, Tingting Bai, Shouzheng Ma, Fenghua Xu, Yuxin Tang, Ying Han, Junlong Zhao, Xingshun Qi, Jing Li, Xilin Du, Dongfeng Chen, Lei Liu
Publikováno v:
Frontiers in Oncology, Vol 12 (2023)
BackgroundHepatoma arterial-embolization prognostic (HAP) series scores have been proposed for prognostic prediction in patients with unresectable hepatocellular carcinoma (uHCC) undergoing transarterial chemoembolization (TACE). However, their progn
Externí odkaz:
https://doaj.org/article/d3c3a7749e944cef8c194459c1e5fd3f
Autor:
Jun Zhu, Tenghui Han, Shoujie Zhao, Yejing Zhu, Shouzheng Ma, Fenghua Xu, Tingting Bai, Yuxin Tang, Yungang Xu, Lei Liu
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Necroptosis is a programmed form of necrotic cell death in regulating cancer ontogenesis, progression, and tumor microenvironment (TME) and could drive tumor-infiltrating cells to release pro-inflammatory cytokines, incurring strong immune responses.
Externí odkaz:
https://doaj.org/article/421812703d6145689381b0ca0b6cb548
Autor:
Junlong Zhao, Huichen Li, Shoujie Zhao, Enxin Wang, Jun Zhu, Dayun Feng, Yejing Zhu, Weijia Dou, Qingling Fan, Jie Hu, Lintao Jia, Lei Liu
Publikováno v:
Molecular Cancer, Vol 20, Iss 1, Pp 1-16 (2021)
Abstract Background & Aims Hepatocellular carcinoma (HCC) is among the malignancies with the highest mortality. The key regulators and their interactive network in HCC pathogenesis remain unclear. Along with genetic mutations, aberrant epigenetic par
Externí odkaz:
https://doaj.org/article/d3e029ce3ea0472aa80f1d1d0a86c903
Autor:
Yang Bai, Enxin Wang, Shoujie Zhao, Jing Li, Yejing Zhu, Yongchao Zhang, Liang Cao, Haitao Liu, Yushu Dong, Fang Wang, Guobiao Liang, Lei Liu
Publikováno v:
Frontiers in Medicine, Vol 8 (2021)
Background: Although laboratory tests have become an indispensable part in clinical practice, its application in severity classification and death risk stratification of COVID-19 remains unvalidated. This study aims to explore the significance of lab
Externí odkaz:
https://doaj.org/article/6fac2aa52d45490facc766c979b06613
Publikováno v:
Experimental and Therapeutic Medicine. 26
Autor:
Jun Zhu, Enxin Wang, Shoujie Zhao, Shouzheng Ma, Tingyu Shi, Dandan Han, Tenghui Han, Tingting Bai, Yuxin Tang, Fenghua Xu, Tenghai Chen, Jing Li, Hui Chen, Chenyu Zhang, Yan Zhao, Yang Bai, Yanju Lou, Jiahao Fan, Yongchao Zhang, Wenbing Wu, Man Yang, Xing Chen, Jia Jia, Yejing Zhu, Linxing Chen, Jun long Zhao, Xilin Du, Dongfeng Chen, Ying Han, Guohong Han, Lei Liu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5beab95864646f86e39739c62cc7d473
https://doi.org/10.2139/ssrn.4411423
https://doi.org/10.2139/ssrn.4411423
Autor:
Shouzheng Ma, Jun Zhu, Enxin Wang, Shoujie Zhao, Yang Bai, Junlong Zhao, Jing Li, Yejing Zhu, Tingting Bai, Dandan Han, Fenghua Xu, Hui Chen, Yongchao Zhang, Yan Zhao, Jiahao Fan, Yanju Lou, Man Yang, Xing Chen, Jia Jia, Wenbing Wu, Chenyu Zhang, Yuxin Tang, Xingshun Qi, Dongfeng Chen, Rui Wang, Ying Han, Lei Liu
Background: Liver transplantation (LT) is the optimal treatment option for hepatocellular carcinoma (HCC) meeting the Extended Liver Transplant Criteria (ELTC), but it is only offered for the minority. The optimal alternative strategy for HCCs beyond
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::010e3e915f8106ed627e7558e137cbf0
https://doi.org/10.21203/rs.3.rs-2373817/v1
https://doi.org/10.21203/rs.3.rs-2373817/v1